|
1
|
Messerschmitt PJ, Garcia RM, Abdul-Karim
FW, Greenfield EM and Getty PJ: Osteosarcoma. J Am Acad Orthop
Surg. 17:515–527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu W, Tang L, Lin F, Yao Y, Shen Z and
Zhou X: High-intensity focused ultrasound: noninvasive treatment
for local unresectable recurrence of osteosarcoma. Surg Oncol.
24:9–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bacci G, Ferrari S, Bertoni F, Ruggieri P,
Picci P, Longhi A, Casadei R, Fabbri N, Forni C, Versari M and
Campanacci M: Long-term outcome for patients with nonmetastatic
osteosarcoma of the extremity treated at the istituto ortopedico
rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2
protocol: An updated report. J Clin Oncol. 18:4016–4027. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye B, Liu B, Yang L, Zhu X, Zhang D, Wu W,
Zhu P, Wang Y, Wang S, Xia P, et al: LncKdm2b controls self-renewal
of embryonic stem cells via activating expression of transcription
factor Zbtb3. EMBO J. 37:pii: e97174. 2018. View Article : Google Scholar
|
|
7
|
Liu B, Ye B, Yang L, Zhu X, Huang G, Zhu
P, Du Y, Wu J, Qin X, Chen R, et al: Long noncoding RNA lncKdm2b is
required for ILC3 maintenance by initiation of Zfp292 expression.
Nat Immunol. 18:499–508. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang C, Wu K, Wang S and Wei G: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
YAP via miR-195-5p. J Cell Biochem. Jan 31–2018.(Epub ahead of
print). View Article : Google Scholar :
|
|
9
|
Dong X, Chen R, Lin H, Lin T and Pan S:
lncRNA BG981369 inhibits cell proliferation, migration, and
invasion, and promotes cell apoptosis by SRY-related high-mobility
group box 4 (SOX4) signaling pathway in human gastric cancer. Med
Sci Monit. 24:718–726. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bai JG, Tang RF, Shang JF, Qi S, Yu GD and
Sun C: Upregulation of long non-coding RNA CCAT2 indicates a poor
prognosis and promotes proliferation and metastasis in intrahepatic
cholangiocarcinoma. Mol Med Rep. 17:5328–5335. 2018.PubMed/NCBI
|
|
11
|
Cheng Y, Imanirad P, Jutooru I, Hedrick E,
Jin UH, Hoffman Rodrigues A, de Leal Araujo J, Morpurgo B, Golovko
A and Safe S: Role of metastasis-associated lung adenocarcinoma
transcript-1 (MALAT-1) in pancreatic cancer. PLoS One.
13:e01922642018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang P, Zhou H, Lu K, Lu Y, Wang Y and
Feng T: Exosome-mediated delivery of MALAT1 induces cell
proliferation in breast cancer. Onco Targets Ther. 11:291–299.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen X, Chen Z, Yu S, Nie F, Yan S, Ma P,
Chen Q, Wei C, Fu H, Xu T, et al: Long noncoding RNA LINC01234
functions as a competing endogenous RNA to regulate CBFB expression
by sponging miR-204-5p in gastric cancer. Clin Cancer Res.
24:2002–2014. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B,
Du Y, Gao G, Tian Y, He L and Fan Z: LncBRM initiates YAP1
signalling activation to drive self-renewal of liver cancer stem
cells. Nat Commun. 7:136082016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren J, Yang Y, Xue J, Xi Z, Hu L, Pan SJ
and Sun Q: Long noncoding RNA SNHG7 promotes the progression and
growth of glioblastoma via inhibition of miR-5095. Biochem Biophys
Res Commun. 496:712–718. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dai W, Tian Y, Jiang B and Chen W:
Down-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor
growth, promotes apoptosis and decreases metastasis in thyroid
cancer. Biomed Pharmacother. 99:191–197. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang ZY, Hu M, Dai MH, Xiong J, Zhang S,
Wu HJ, Zhang SS and Gong ZJ: Upregulation of the long non-coding
RNA AFAP1-AS1 affects the proliferation, invasion and survival of
tongue squamous cell carcinoma via the Wnt/β-catenin signaling
pathway. Mol Cancer. 17:32018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han X, Wang L, Ning Y, Li S and Wang Z:
Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes
metastasis in colorectal cancer. Biol Res. 49:362016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q,
Wu JY, Qin J, Jin T and Xu JM: Long noncoding RNA AFAP1-AS1
indicates a poor prognosis of hepatocellular carcinoma and promotes
cell proliferation and invasion via upregulation of the RhoA/Rac2
signaling. Int J Oncol. 48:1590–1598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng J, Liang Y, Liu C, He S and Wang S:
The up-regulation of long non-coding RNA AFAP1-AS1 is associated
with the poor prognosis of NSCLC patients. Biomed Pharmacother.
75:8–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marchese FP, Raimondi I and Huarte M: The
multidimensional mechanisms of long noncoding RNA function. Genome
Biol. 18:2062017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu P, Wang Y, Huang G, Ye B, Liu B, Wu J,
Du Y, He L and Fan Z: lnc-β-Catm elicits EZH2-dependent β-catenin
stabilization and sustains liver CSC self-renewal. Nat Struct Mol
Biol. 23:631–639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin T, Ma Q, Zhang Y, Zhang H, Yan J and
Gao C: MicroRNA-27a functions as an oncogene in human osteosarcoma
by targeting CCNG1. Oncol Lett. 15:1067–1071. 2018.PubMed/NCBI
|
|
25
|
Han C and Wang W: MicroRNA-129-5p
suppresses cell proliferation, migration and invasion via targeting
ROCK1 in osteosarcoma. Mol Med Rep. 17:4777–4784. 2018.PubMed/NCBI
|
|
26
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of
beta-catenin-Tcf signaling in colon cancer by mutations in
beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Xiao X, Chen X, Huo Y, Xi WJ, Lin
ZF, Zhang D, Li YF, Yang F, Wen WH, et al: Tumor-suppressive
miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms
double-negative regulation loops with its negative regulators in
colorectal cancer. Int J Cancer. 142:308–321. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ishiguro H, Wakasugi T, Terashita Y,
Sakamoto N, Tanaka T, Sagawa H, Okubo T and Takeyama H: Nuclear
expression of TCF4/TCF7L2 is correlated with poor prognosis in
patients with esophageal squamous cell carcinoma. Cell Mol Biol
Lett. 21:52016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao W, Zhou J, Deng Z, Gao Y and Cheng Y:
SPOP promotes tumor progression via activation of β-catenin/TCF4
complex in clear cell renal cell carcinoma. Int J Oncol.
49:1001–1008. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Q, Gao M, Luo G, Han X, Bao W, Cheng
Y, Tian W, Yan M, Yang G and An J: Enhancement of radiation
sensitivity in lung cancer cells by a novel small molecule
inhibitor that targets the β-catenin/Tcf4 interaction. PLoS One.
11:e01524072016. View Article : Google Scholar : PubMed/NCBI
|
